Pulse Biosciences, Inc. PLSE Accrued liabilities
Accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s accrued liabilities?
- Pulse Biosciences, Inc. (PLSE) reported accrued liabilities of $1.83M in Q1 2026.
- How has Pulse Biosciences, Inc.'s accrued liabilities changed year-over-year?
- Pulse Biosciences, Inc.'s accrued liabilities increased by 160.2% year-over-year, from -$3.04M to $1.83M.